Genetic changes in clinically organ-confined prostate cancer by comparative genomic hybridization

Urology

Volumn 56, Issue 5, 2000, Pages 880-885

  Fu, Wenting ^a   Bubendorf, Lukas ^a   Willi, Niels ^a   Moch, Holger ^a   Mihatsch, Michael J ^a   Sauter, Guido ^a   Gasser, Thomas C ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CHROMOSOME 18Q; CHROMOSOME 8Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; DNA SEQUENCE; GENOME; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, PAIR 8; DISEASE PROGRESSION; DNA PROBES; DNA, NEOPLASM; HUMAN; MALE; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS; SUPPORT, NON-U.S. GOV'T; X CHROMOSOME;

EID: 0033783198     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(00)00722-6     Document Type: Article

References (30)

1. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking
2. Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological Stage C (pT3N0M0) prostate carcinoma
3. Allelic losses on 18q21 are associated with progression and metastasis in human prostate cancer
4. Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer
5. Histologic grading and clinical staging of prostatic carcinoma
6. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization
7. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization
8. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping
9. A similar pattern of chromosomal alterations in prostate cancers from African-Americans and Caucasian Americans
10. Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization
11. Comparative genomic hybridization reveals DNA copy number gains to frequently occur in human prostate cancer
12. Adenocarcinoma of the prostate invading the seminal vesicle; definition and relation of tumor volume, grade and margins of resection to prognosis
13. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer
14. Allelic loss of chromosome 18q and prognosis in colorectal cancer
15. Prognostic significance of accumulation of gene and chromosome alterations and histological grade in node-negative breast carcinoma
16. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
17. Identification of a chromosome 18q gene that is altered in colorectal cancers
18. Interphase cytogenetics of prostatic tumor progression; specific chromosomal abnormalities are involved in metastasis to the bone
19. Clinical significance of alterations of chromosome 8 in high-grade, advanced, non-metastatic prostate carcinoma
20. Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridisation on tissue microarrays
21. Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer
22. Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced cancer
23. Localization of a tumor suppressor gene associated with progression of human prostate cancer within a 1.2 Mb region of 8p22-p21.3
24. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma
25. Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia
26. Interphase cytogenetic analysis of prostatic carcinomas by use of nonisotopic in situ hybridization
27. Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization
28. In vivo amplification of the androgen receptor gene and progression of human prostate cancer
29. Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer